CEO
Inquis Medical
Inquis Medical is developing the AVENTUS Thrombectomy System, which utilizes proprietary TrueClot™ sensing technology for precise directional aspiration and efficient single-pass thrombectomy with minimal blood loss. This system addresses the critical need for effective removal of emboli and thrombi in patients suffering from venous thromboembolism (VTE).
- Hardware
- Healthcare Technology
- Medical Devices
Updated 23 months ago
Funding
Raised to date
$48MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Problem
Venous thromboembolism (VTE), encompassing deep vein thrombosis (DVT) and pulmonary embolism (PE), poses a significant threat, with high mortality rates and long-term complications. Traditional thrombectomy methods can be limited by multiple wire exchanges, empty aspirations, vessel wall latching, and potential blood loss, hindering efficient and safe clot removal.
Solution
The AVENTUS Thrombectomy System offers a fully integrated solution for the non-surgical removal of emboli and thrombi from blood vessels. The system combines navigation, aspiration, and blood return with proprietary TrueClot™ sensing technology to enhance ease of use and precision during mechanical thrombectomy procedures. TrueClot™ sensing enables precise directional aspiration, minimizing empty aspirations and reducing vessel wall latching. The system is designed for single-pass thrombectomy with minimal wire exchanges and streamlined blood return.
Target Audience
The primary target audience includes interventional radiologists, vascular surgeons, and other healthcare providers who perform thrombectomy procedures for patients with VTE.
Features
- Proprietary TrueClot™ sensing technology for real-time clot detection and differentiation
- Precise directional aspiration for targeted clot removal
- Integrated system combining navigation, aspiration, and blood return
- Single-pass thrombectomy capability, minimizing procedure time
- Reduced vessel wall latching to minimize risk of vessel damage
- Streamlined blood return for efficient blood management
- Intended for use in the peripheral vasculature